Northwestern Medicine investigators have identified issues with most genomic sequence data for the Neisseria gonorrhoeae bacterium, findings that could complicate future epidemiological and ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections in decades, and the first developed as part of a public-private ...

Neisseria gonorrhoeae, the microbe responsible for gonorrhoea, is developing resistance to most antibiotics, which means we need new drugs to treat the condition. An antibiotic called zoliflodacin mig ...

Neisseria gonorrhoeae bacteria, as seen in this illustration, consist of a pair of cells, called diplococci, and have hair-like pili on their surfaces. They can cause the sexually transmitted ...

Gonorrhea is a common sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. It primarily infects the ...

Phase 3 findings show oral zoliflodacin to be non-inferior to the combination of ceftriaxone and azithromycin for the treatment of uncomplicated urogenital gonorrhea.Positive study results are a ...

For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection is ...

The bacteria that causes the clap is growing resistant to available treatments. July 11,2011— -- Scientists have discovered a new strain of gonorrhea-causing bacteria in Japan that is resistant ...